Greek English

Contracted laboratory for Biomarkers

BIOANALYTICA GENOTYPE SA was established in December 2004 as a biotech startup aiming to provide specialised molecular cytogenetic research and application services to the biomedical Community.

 

Was funded by BIOANALYTICA SA, a leading stakeholder in the greek market for molecular diagnostics and laboratory infrastructure, and by the researcher Dr. Georgia Bardi, Associate Professor of Experimental Clinical Genetics at the Medical school of Lund University, Sweden and former Director of the Cytogenetics facility at Saint Savas Oncology hospital of Athens.

 

Is co-financed by the Greek General Secretariat of Research and Technology under the 3rd Community Support Program (03 Praxe 26).

 

 

A.E: 27th National Congress of Haematology

A.E: 27th National Congress of Haematology

ΒιοΑναλυτική-ΓενόΤυπος

The organizing and Scientific Committee of the 27th National Conference chose asAimatologikoy oral communication work titled "Multi-center Record variations in chromosome swap Ph in patients with years of myeloid leukemia-preliminary results".

 

The announcement, which is a collaborative effort of three centres, one of which is and the laboratory of Bioanalytical-GenoTypos, will be presented at the session of Friday November 4th, 16.30-17.30, room FILIPPOS Conference Center i. Vellidis in Thessaloniki.

BioAnalytica-Genotype SA serves the healthcare market by offering Cytogenetics and Molecular Genetics tests, designed to answer questions related to diagnosis, prognosis and therapy selection for hematologic and solid tumor cancers.